Editors-in-Chief: Amedeo Lonardo, Youfei Guan
Median time to first editorial decision: 6 days

Metabolism and Target Organ Damage

Articles

Most Recent | Most Viewed | Most Downloaded

Why wait? Early combination therapy in diabetic kidney disease: lessons from CONFIDENCE

Open Access Commentary DOI: 10.20517/mtod.2026.132 8 Sep 2026
Views: Downloads:
Download PDF

MASLD epidemiology, natural history and diagnosis

Open Access Review DOI: 10.20517/mtod.2026.114 28 Aug 2026
Views: Downloads:
Download PDF

Insulin physiology and metabolic control: current concepts and perspectives

Open Access Review DOI: 10.20517/mtod.2026.80 28 Aug 2026
Views: Downloads:
Download PDF

Triglyceride-glucose waist-to-weight index and bone microarchitecture in type 2 diabetes: a machine-learning and regression analysis

Open Access Original Article DOI: 10.20517/mtod.2025.223 28 Aug 2026
Views: Downloads:
Download PDF

Extracellular vesicle-mediated communication in diabetic cardiomyopathy: cellular mechanisms, metabolic remodeling, and emerging therapeutic strategies

Open Access Review DOI: 10.20517/mtod.2026.120 26 Aug 2026
Views: Downloads:
Download PDF

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Open Access Review DOI: 10.20517/mtod.2024.07 6 Apr 2024
Views: Downloads:
Download PDF

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Open Access Review DOI: 10.20517/mtod.2024.42 14 Nov 2024
Views: Downloads:
Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024
Views: Downloads:
Download PDF

Topic: Obesity Treatment and Disease Modification

Submission Deadline: 31 Mar 2027

Published articles: 0

Topic: Cardiometabolic Drug Repurposing and Systemic Disease Burden

Submission Deadline: 31 Mar 2027

Published articles: 0

Coming soon.

How steatosis, fibrosis, and alcohol biomarkers reshape assessment and drug development in metabolic dysfunction-associated alcohol-related liver disease
Ranked 73/198 in Endocrinology & Metabolism (Q2, 30%), demonstrating stable performance and sustained academic influence in the latest Clarivate evaluation.
A mini review highlights the key roles of lipid droplets, lipophagy, and ER stress in orchestrating hepatic repair
Explore how male and female biology shapes MASLD risk and treatment - read more inside!
A Special Issue led by Dr. Donghee Kim from Stanford University School of Medicine is now open and welcomes submissions.

Topic: Obesity Treatment and Disease Modification

Submission Deadline: 31 Mar 2027

Published articles: 0

Topic: Cardiometabolic Drug Repurposing and Systemic Disease Burden

Submission Deadline: 31 Mar 2027

Published articles: 0

Coming soon.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/